Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide for Indian patients on Monjuvi (tafasitamab-cxix) dosage, administration, treatment schedules, and what to expect during therapy for diffuse large B cell lymphoma.
Monjuvi (tafasitamab-cxix) is a vital medication used in the treatment of certain types of diffuse large B cell lymphoma (DLBCL) that have either returned after previous treatment or have not responded to other therapies. As a biologic drug, it is derived from living cells and works by targeting specific proteins on cancer cells. Understanding the dosage, how it's administered, and what to expect is crucial for patients undergoing this treatment. This guide aims to provide clear, practical information for Indian patients about Monjuvi dosage, administration, and related aspects.
Diffuse large B cell lymphoma is an aggressive type of non-Hodgkin lymphoma. It originates from B-cells, a type of white blood cell. In DLBCL, these B-cells grow uncontrollably and can form tumors in lymph nodes, spleen, bone marrow, blood, or other organs. When DLBCL returns or doesn't respond to initial treatments, options like Monjuvi become important.
The dosage of Monjuvi is primarily based on your body weight. The standard recommendation is 12 milligrams per kilogram (mg/kg) of body weight. Your doctor will calculate the exact dose needed for you based on your current weight.
Example Calculation:
This calculated dose is then prepared for administration.
Monjuvi is not taken orally. It is given as an intravenous (IV) infusion, which means it is injected directly into a vein over a period of time. This is typically done at a doctor's office, a healthcare facility, or a specialized infusion center.
Preparation:
Infusion Duration:
Monjuvi treatment is given in cycles, with each cycle lasting 28 days. The frequency and timing of infusions change throughout the treatment course, often in combination with other medications like lenalidomide (Revlimid).
Typical Dosing Schedule:
Combination Therapy:
Your doctor will provide the exact schedule tailored to your specific treatment plan.
To help your body manage the infusion and reduce the risk of negative reactions, you might be asked to arrive early for your appointment. This allows time for premedications to be given. These are medications administered 30 minutes to 2 hours before your Monjuvi infusion.
Throughout your Monjuvi treatment, your healthcare team will closely monitor you. This includes:
Based on your blood test results, how your body tolerates the medication, and any reactions you experience, your doctor may decide to:
While the drug manufacturer does not have specific dosage adjustment guidelines for liver or kidney issues, your doctor will closely monitor your kidney and liver function. If these functions worsen during treatment, your doctor might consider changing your medication.
Monjuvi is typically considered a long-term treatment. The decision to continue treatment is made jointly by you and your doctor. Generally, you will continue to receive Monjuvi until your lymphoma progresses (gets worse) or you experience side effects that are too severe or cannot be managed.
It is essential to communicate openly with your healthcare team. You should consult your doctor or nurse immediately if you experience any of the following:
Monjuvi is available in a strength of 200 mg of powder in a single-dose vial.
No, Monjuvi is administered as an IV infusion by a healthcare professional at a clinic or infusion center. It cannot be taken at home.
If you miss an appointment, contact your doctor's office immediately to reschedule. Do not try to self-administer or adjust your schedule without medical guidance.
Common side effects can include low blood cell counts (anemia, neutropenia, thrombocytopenia), fatigue, diarrhea, fever, and upper respiratory tract infections. Your doctor will monitor you for these and manage them as needed.
The treatment duration varies depending on the individual's response and tolerance. It can involve multiple cycles, often continuing for many months or until the disease progresses or side effects become unmanageable.
Disclaimer: This information is intended for educational purposes and should not replace professional medical advice. Always consult with your doctor or qualified healthcare provider for any questions regarding your medical condition or treatment.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026